News & Events

Fostering North American partnerships

August 16, 2016

Sethuraman "Panch" Panchanathan (left), senior vice president for ASU's Knowledge Enterprise Development; Joshua LaBaer, an executive with the Biodesign Institute; and Luis Armando Kuroda of Mexico's Salud Digna and Fundación Vizcarra (right) sign a memorandum of understanding (MOU) on Aug. 15. The MOU establishes a commitment to collaborate using ASU's undergraduate and graduate scientific researchers and Salud Digna's preventative health-care services with the goal of bringing greater...

Students unlock career options through summer brain research

August 16, 2016

Rather than swimming and picnics, 19 students conducted brain research for eight weeks this summer as part of the Banner Research/ASU-Biodesign Summer Internship Program. Students ranging from high school to college levels competed for projects in clinical, basic laboratory or computational medical imaging research to explore the aging brain. They were then matched with scientists and technologists at Banner Sun Research Institute, ASU Biodesign Institute or Banner Alzheimer’s Institute...

LaBaer advances disease research, claims important award

July 15, 2016

Josh LaBaer, M.D., PhD., a leading researcher in the rapidly expanding field of proteomics, has just been awarded the 2016 Translational Proteomics Award from the Human Proteome Organization (or HUPO). The prestigious award recognizes professor LaBaer’s distinguished scientific achievements in the field of translational proteomics science. HUPO is an international scientific organization promoting proteomics through international cooperation and collaboration, fostering the development of...

ASU reaches next milestone in multi-million dollar program to develop an automated, high-throughput diagnostic test for estimating absorbed radiation

June 15, 2016

Arizona State University’s Biodesign Institute announced today it is entering a new, $7M phase of a multi-million, multi-institutional development project to produce a diagnostic test to measure an individual’s level of absorbed radiation in the event of an unplanned radiological or nuclear event. Currently, there is no U.S. Food and Drug Administration cleared or approved, high-throughput system to measure the radiation dose absorbed by individuals within a large population. The ASU...

International collaboration reaches milestone in curating new resource for unraveling human disease

February 25, 2016

Gene bank collection now totals 80 percent of all human protein-coding genes, collaboration reports An international collaboration of organizations, including Arizona State University’s Biodesign Institute and the Dana-Farber Cancer Institute, has reached a milestone in creating a library of complete genetic blueprints for the thousands of different proteins in human cells, called the human proteome. The collection – consisting of open-reading frames (ORFs), the portions of genes that...

BioPolicy Summit tackles reproducibility of science issues

February 11, 2016

To err is human, even for one of the most number crunching, rigorous and truth seeking of all activities: science. The issue of errors in science --- irreproducible research --- was recently a focal point for a national discussion when the Global Biological Standards Institute (GBSI) hosted its 2016 BioPolicy Summit. The 2016 GBSI Summit—“Research Reproducibility: Innovative Solutions to Drive Quality” welcomed premiere life science thought leaders, including Arizona State University...

LaBaer featured panelist at BioPolicy Summit on research reproducibility

February 2, 2016

ASU Biodesign Institute interim executive director Dr. Joshua LaBaer, MD, PhD, will be headed to the nation's capital next week to participate in an esteemed panel of top bioscience leaders as part of the 2016 Global BioPolicy Summit.  On Tuesday, February 9, at 12:00 noon EST, Global Biological Standards Institute (GBSI) will host its 2016 BioPolicy Summit at the Newseum in Washington, DC. The 2016 Summit—Research Reproducibility: Innovative Solutions to Drive Quality welcomes LaBaer...

ASU names LaBaer interim executive director of the Biodesign Institute

January 13, 2016

Dr. Joshua L. LaBaer, a leading researcher in cancer and personalized medicine, has been named interim executive director for the Biodesign Institute at Arizona State University.   “LaBaer’s leadership will ensure that we continue our progress toward establishing the Biodesign Institute as a world-class research institute focused on solving key societal challenges in health, sustainability and national security,” said Sethuraman Panchanathan, senior vice president of ASU’s Office...

Earlier stage melanoma diagnosis advances with gift from Alliance Beverage

December 30, 2015

If you play golf, an already vexing game may throw another unexpected bogey---you may have an increased chance of getting skin cancer. Fred Couples has had numerous bouts with it, as has Hank Haney, Adam Scott and others. Half of all melanoma deaths in the U.S. are in men over age 50 – and melanoma is one of only three cancers for which mortality in men is increasing. The American Cancer Society predicts there will be 1,400 new cases in Arizona this year alone. Screening and early...

ASU, Mayo Clinic collaborate to advance medicine through joint research

December 1, 2015

2016 seed-grant recipients announced Arizona State University, in partnership with Mayo Clinic in Arizona, has announced the recipients of the 2016 ASU-Mayo Seed Grant Program. The program funds critical joint research projects in the health field led by scientists from both ASU and Mayo Clinic. The awardees this year are making innovative strides in the treatment of cancer, Alzheimer’s, Parkinson’s, heart failure and infectious diseases, as well as advancing nanobody technology and...